Stock Screener App

Gratuito -

Installare

50.28

1.88% 0.90

Supernus Pharmaceuticals Inc (SUPN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SUPN Giù? Forum Previsione

Supernus Pharmaceuticals Inc Borsa (SUPN) Ultime notizie

Jefferies reiterates Supernus Pharmaceuticals stock Buy rating By Investing.com - Investing.com South Africa

Jefferies reiterates Supernus Pharmaceuticals stock Buy rating - Investing.com UK

Breakout Watch: What is the target price for Supernus Pharmaceuticals Inc stockQuarterly Growth Report & Low Volatility Stock Suggestions - baoquankhu1.vn

SUPN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

The Technical Signals Behind (SUPN) That Institutions Follow - Stock Traders Daily

SUPN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

SUPN Technical Analysis & Stock Price Forecast - Intellectia AI

Quarterly Risk: Does Supernus Pharmaceuticals Inc have strong EBITDA margins2026 Technicals & High Accuracy Buy Signal Tips - baoquankhu1.vn

Insider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells 7,250 Shares of Stock - MarketBeat

Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells $2,514,000.00 in Stock - MarketBeat

[Form 4] SUPERNUS PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

Supernus Pharmaceuticals Q4 2025 earnings preview - MSN

SUPN (NASDAQ: SUPN) Form 144 lists 57,250-share resale after option exercise - Stock Titan

SUPN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Supernus Pharmaceuticals CEO Sells $1.76M in Stock - National Today

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - MSN

Insider Sell Alert: Frederick Hudson Sells Shares of Supernus Ph - GuruFocus

[144] SUPERNUS PHARMACEUTICALS, INC. SEC Filing - Stock Titan

Supernus (NASDAQ: SUPN) CEO-linked KBT Trust sells 35,000 shares under 10b5-1 plan - Stock Titan

Director at Supernus (NASDAQ: SUPN) sells 5,369 shares - Stock Titan

SUPN SEC FilingsSupernus Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Mixed Short And Long Term Returns - simplywall.st

Aristotle Capital Boston LLC Sells 503,122 Shares of Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat

Insider sale of 5,369 shares at SUPN (NASDAQ: SUPN) - Stock Titan

Supernus Pharmaceuticals Stock Review: Valuation & Business Quality ConcernsNews and Statistics - IndexBox

3 Reasons SUPN is Risky and 1 Stock to Buy Instead - Yahoo Finance

Supernus at Barclays Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com Canada

To promote Zurzuvae, Biogen and Supernus are Turning Tides against postpartum depression - Medical Marketing and Media

Supernus Pharmaceuticals, Inc. $SUPN Shares Acquired by Jefferies Financial Group Inc. - MarketBeat

Dimensional Fund Advisors LP Lowers Holdings in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat

Supernus (NASDAQ: SUPN) CEO exercises performance units, withholds shares for taxes - Stock Titan

Supernus (SUPN) SVP Mottola sells shares after exercising 3,750 PSUs - Stock Titan

SUPERNUS (NASDAQ: SUPN) CFO exercises performance units, settles taxes in shares - Stock Titan

Supernus (NASDAQ: SUPN) SVP sells 8,877 shares after exercising 7,500 PSUs - Stock Titan

[Form 3] SUPERNUS PHARMACEUTICALS, INC. Initial Statement of Beneficial Ownership - Stock Titan

Precision Trading with Supernus Pharmaceuticals Inc. (SUPN) Risk Zones - Stock Traders Daily

Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Victory Capital Management Inc. - MarketBeat

Todd Horich sells 4,438 SUPN shares (NASDAQ: SUPN) in Form 144 filing - Stock Titan

Insider Selling Alert: Georges Gemayel Sells Shares of Supernus Pharmaceuticals Inc (SUPN) - GuruFocus

Insider Selling: Supernus Pharmaceuticals (NASDAQ:SUPN) Director Sells 10,000 Shares of Stock - MarketBeat

Form 144: Proposed sale of 4,438 shares by SUPN insider (SUPN) - Stock Titan

Director at Supernus (NASDAQ: SUPN) sells 18,787 shares of stock - Stock Titan

American Century Companies Inc. Decreases Position in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat

Recap Report: Is Supernus Pharmaceuticals Inc being accumulated by smart moneyTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn

Supernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Buy" at Wall Street Zen - MarketBeat

Assessing Supernus Pharmaceuticals (SUPN) Valuation After Q4 Results And 2026 Guidance Update - Sahm

B of A Securities Initiates Coverage of Supernus Pharmaceuticals (SUPN) with Buy Recommendation - MSN

Georges Gemayel sells shares under Rule 144 (SUPN) - Stock Titan

Citigroup Inc. Lowers Stake in Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat

GW&K Investment Management LLC Sells 184,268 Shares of Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat

Supernus (NASDAQ: SUPN) CFO receives performance share unit grant - Stock Titan

Supernus Pharmaceuticals (SUPN) CEO awarded 38,640 performance units - Stock Titan

Supernus Pharmaceuticals (SUPN) SVP gets 3,750 performance share units - Stock Titan

Is It Too Late To Consider Supernus Pharmaceuticals (SUPN) After A 74% One-Year Surge? - simplywall.st

Supernus Pharmaceuticals (SUPN) Stock Analysis: A 14.66% Upside and Strong Buy Ratings Shape Investor Outlook - DirectorsTalk Interviews

Is It Too Late To Consider Supernus Pharmaceuticals (SUPN) After A 74% One Year Rally? - Yahoo Finance

Envestnet Asset Management Inc. Sells 63,513 Shares of Supernus Pharmaceuticals, Inc. $SUPN - MarketBeat

Decoding Supernus Pharmaceuticals Inc (SUPN): A Strategic SWOT I - GuruFocus

Supernus at TD Cowen Conference: Strategic Diversification Unveiled By Investing.com - Investing.com South Africa

Supernus at TD Cowen Conference: Strategic Diversification Unveiled - Investing.com

RDY

$13.94

3.61%

RGC

$24.96

1.93%

ELAN

$25.41

2.01%

NBIX

$131.82

3.10%

VTRS

$13.55

1.46%

UTHR

$547.58

2.98%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters